Key Market Indicator:
F&G: 47
25.120,85 NASDAQ · 48.053,50 DOW · 6.795,45 S&P · 4.303,73 Gold · 58,83 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
© EQS Newswire
21.10.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments publishes Half-Year Report as at 30 September 2024 with key figures for the first six months of the 2024/2025 financial year
News Preview
Profit of CHF 23 million NAV up by 1.5 percent and share price up by 1.7 percent Private as well as public portfolio companies contribute to earnings Unfavourable currency movements impact performance by almost 5 percent   Successful first half – currency effects impact performance HBM Healthcare Investments generated a profit of CHF 23 milli......
Themefolio
Profiler
Peergroup
© EQS Newswire
21.10.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments erzielt im ersten Halbjahr des Geschäftsjahres 2024/2025 einen Gewinn von CHF 23 Millionen; Währungseffekte belasteten Ergebnis stark
News Preview
Gewinn von CHF 23 Millionen NAV steigt um 1.5 Prozent und Aktienkurs um 1.7 Prozent Private und börsenkotierte Portfoliounternehmen tragen zum Gewinn bei Ungünstige Währungsentwicklungen belasten Performance mit knapp 5 Prozent   Erfolgreiches Halbjahr – Währungseffekte schmälern Performance HBM Healthcare Investments erzielte in den ersten ......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 15.10.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.10.2024 16.10.2024 / 17:47 CET/CEST   in CHF Performance in %   15.10.2024   MTD FYTD CYTD NAV 249.16 2.0 3.4 ......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar

USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© EQS Newswire
14.10.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM portfolio company Upstream Bio raises USD 255 million in successful initial public offering
News Preview
HBM Healthcare Investments AG / Key word(s): IPO HBM portfolio company Upstream Bio raises USD 255 million in successful initial public offering 14.10.2024 / 06:30 CET/CEST Upstream Bio (Nasdaq: UPB), a previously private company in the HBM Healthcare Investments portfolio, got off to a successful start on the stock m......
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© EQS Newswire
14.10.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Erfolgreicher Börsengang des HBM-Portfoliounternehmens Upstream Bio; Kapitalaufnahme von USD 255 Millionen
News Preview
HBM Healthcare Investments AG / Schlagwort(e): Börsengang Erfolgreicher Börsengang des HBM-Portfoliounternehmens Upstream Bio; Kapitalaufnahme von USD 255 Millionen 14.10.2024 / 06:30 CET/CEST Upstream Bio (Nasdaq: UPB), ein bisher privates Unternehmen aus dem Portfolio von HBM Healthcare Investments, legte am vergang......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 30.9.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 30.9.2024 01.10.2024 / 17:47 CET/CEST   in CHF Performance in %   30.09.2024   MTD FYTD CYTD NAV 244.34 5.6 1.5 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments erzielt im ersten Halbjahr des Geschäftsjahres 2024/2025 einen Gewinn von CHF 23 Millionen; Währungseffekte belasteten Ergebnis stark
News Preview
HBM Healthcare Investments hat in der ersten Hälfte  des Geschäftsjahrs 2024/2025 eine positive Performance erzielt. Der innere Wert je Aktie (NAV) stieg um 1.5 Prozent auf CHF 244.34. Der Aktienkurs legte um 1.7 Prozent auf CHF 189.40 zu. Auf Basis des ausgewiesenen NAV erwartet die Gesellschaft einen Halbjahresgewinn von rund CHF 23 Millionen (V......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments posts half-year profit of CHF 23 million for 2024/2025 financial year; currency effects had a strong negative impact on the result
News Preview
HBM Healthcare Investments achieved a positive performance in the first half of the 2024/2025 financial year. The net asset value per share (NAV) increased by 1.5 per cent to CHF 244.34. The share price rose by 1.7 per cent to CHF 189.40. Based on the reported NAV, the company expects a half-year profit of around CHF 23 million (previous year: los......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.09.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 15.9.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.9.2024 16.09.2024 / 17:47 CET/CEST   in CHF Performance in %   15.09.2024   MTD FYTD CYTD NAV* 229.03 -1.0 -4.7 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.09.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 15.9.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.9.2024 16.09.2024 / 17:47 CET/CEST   in CHF Performance in %   15.09.2024   MTD FYTD CYTD NAV* 229.03 -1.0 -4.7 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.09.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 31.8.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.8.2024 02.09.2024 / 17:46 CET/CEST   in CHF Performance in %   31.08.2024   MTD FYTD CYTD NAV* 231.29 -1.8 -3.8 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.08.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 15.8.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.8.2024 16.08.2024 / 17:47 CET/CEST   in CHF Performance in %   15.08.2024   MTD FYTD CYTD NAV* 232.50 -1.3 -3.3 ......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
02.08.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 31.7.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.7.2024 02.08.2024 / 17:46 CET/CEST   in CHF Performance in %   31.07.2024   MTD FYTD CYTD NAV 243.25 -3.5 -2.0 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
19.07.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments publishes Quarterly Report as at 30 June 2024 with key figures for the first three months of the 2024/2025 financial year
News Preview
Quarterly profit of CHF 26 million NAV increases by 1.6 percent and share price rises by 5.9 percent Private portfolio companies as value drivers   Positive start to the new financial year HBM Healthcare Investments started the new 2024/2025 financial year with a quarterly profit of CHF 26 million. The net asset value per share (NAV) rose by ......
Themefolio
Profiler
Peergroup
© EQS Newswire
19.07.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments publiziert Quartalsbericht per 30. Juni 2024 mit Kennzahlen für die ersten drei Monate des Geschäftsjahrs 2024/2025
News Preview
Quartalsgewinn von CHF 26 Millionen NAV steigt um 1.6 Prozent und Aktienkurs um 5.9 Prozent Private Portfoliounternehmen als Werttreiber   Positiver Start ins neue Geschäftsjahr HBM Healthcare Investments startete mit einem Quartalsgewinn von CHF 26 Millionen in das neue Geschäftsjahr 2024/2025. Der innere Wert je Aktie (NAV) stieg in diesen ......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.07.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 15.7.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.7.2024 16.07.2024 / 17:46 CET/CEST   in CHF Performance in %   15.07.2024   MTD FYTD CYTD NAV 251.97 0.0 1.6 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.07.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 30.06.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 30.06.2024 01.07.2024 / 17:46 CET/CEST   in CHF Performance in %   30.06.2024   MTD FYTD CYTD NAV 252.07 -1.8 1.6 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Generalversammlung der HBM Healthcare Investments stimmt allen Anträgen des Verwaltungsrats zu
News Preview
HBM Healthcare Investments AG / Schlagwort(e): Generalversammlung Generalversammlung der HBM Healthcare Investments stimmt allen Anträgen des Verwaltungsrats zu 17.06.2024 / 17:53 CET/CEST Die Aktionärinnen und Aktionäre haben an der heutigen ordentlichen Generalversammlung der HBM Healthcare Investments AG allen Antr......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
News Preview
HBM Healthcare Investments AG / Key word(s): AGMEGM Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors 17.06.2024 / 17:53 CET/CEST At today’s ordinary Shareholders’ Meeting of HBM Healthcare Investments Ltd the shareholders approved al......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 15.06.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.06.2024 17.06.2024 / 17:46 CET/CEST   in CHF Performance in %   15.06.2024   MTD FYTD CYTD NAV 251.13 -2.2 1.2 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 15.06.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.06.2024 17.06.2024 / 17:46 CET/CEST   in CHF Performance in %   15.06.2024   MTD FYTD CYTD NAV 251.13 -2.2 1.2 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.06.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 31.05.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.05.2024 03.06.2024 / 17:46 CET/CEST   in CHF Performance in %   31.05.2024   MTD FYTD CYTD NAV 256.74 0.8 3.5 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM-Portfoliounternehmen Yellow Jersey Therapeutics wird für USD 1.25 Milliarden übernommen
News Preview
Bestätigung für die wegweisenden Wissenschaft und Innovation des Schweizer Biotech-Unternehmens; Transaktion erhöht den NAV pro HBM-Aktie um CHF 8.70 (+3,5%); erwarteter Mittelzufluss von USD 78 Millionen für HBM Healthcare Investments. HBM Healthcare Investments (SIX: HBMN) gab heute bekannt, dass Yellow Jersey Therapeutics, eine Portfoliogesell......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
News Preview
Validation for the pioneering science and innovation of the Swiss biotech company; Transaction increases NAV per HBM share by CHF 8.70 (+3.5%); expected cash inflow of USD 78 million for HBM Healthcare Investments. HBM Healthcare Investments (SIX: HBMN) today announced that Yellow Jersey Therapeutics, a portfolio company......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM-Portfoliounternehmen Yellow Jersey Therapeutics wird für USD 1.25 Milliarden übernommen
News Preview
Bestätigung für die wegweisenden Wissenschaft und Innovation des Schweizer Biotech-Unternehmens; Transaktion erhöht den NAV pro HBM-Aktie um CHF 8.70 (+3,5%); erwarteter Mittelzufluss von USD 78 Millionen für HBM Healthcare Investments. HBM Healthcare Investments (SIX: HBMN) gab heute bekannt, dass Yellow Jersey Therapeutics, eine Portfoliogesell......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
News Preview
Validation for the pioneering science and innovation of the Swiss biotech company; Transaction increases NAV per HBM share by CHF 8.70 (+3.5%); expected cash inflow of USD 78 million for HBM Healthcare Investments. HBM Healthcare Investments (SIX: HBMN) today announced that Yellow Jersey Therapeutics, a portfolio company......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.05.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
News Preview
HBM Healthcare Investments AG / Key word(s): Acquisition HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America 22.05.2024 / 18:17 CET/CEST Swixx BioPharma, the largest investment in the private equity portfolio of HBM Healthcare Investment......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.05.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments’ Portfoliounternehmen Swixx BioPharma stärkt Umsatz und Gewinn durch strategische Übernahme in Lateinamerika
News Preview
HBM Healthcare Investments AG / Schlagwort(e): Ankauf HBM Healthcare Investments’ Portfoliounternehmen Swixx BioPharma stärkt Umsatz und Gewinn durch strategische Übernahme in Lateinamerika 22.05.2024 / 18:17 CET/CEST Swixx BioPharma, die grösste Beteiligung im Private-Equity-Portfolio der HBM Healthcare Investments, ......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.05.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments’ Portfoliounternehmen Swixx BioPharma stärkt Umsatz und Gewinn durch strategische Übernahme in Lateinamerika
News Preview
HBM Healthcare Investments AG / Schlagwort(e): Ankauf HBM Healthcare Investments’ Portfoliounternehmen Swixx BioPharma stärkt Umsatz und Gewinn durch strategische Übernahme in Lateinamerika 22.05.2024 / 17:46 CET/CEST Swixx BioPharma, die grösste Beteiligung im Private-Equity-Portfolio der HBM Healthcare Investments, ......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.05.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
News Preview
HBM Healthcare Investments AG / Key word(s): Acquisition HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America 22.05.2024 / 17:46 CET/CEST Swixx BioPharma, the largest investment in the private equity portfolio of HBM Healthcare Investment......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.05.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 15.05.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.05.2024 16.05.2024 / 17:47 CET/CEST   in CHF Performance in %   15.05.2024   MTD FYTD CYTD NAV 252.23 -1.0 1.7 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.05.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments erzielt im Geschäftsjahr 2023/2024 ein ausgeglichenes Ergebnis
News Preview
Geringer Verlust von CHF 1 Million Innerer Wert pro Aktie (NAV) nach Aktienrückkäufen um 0.3% höher Portfolioentwicklung uneinheitlich Ungünstige Währungsentwicklungen schmälern Jahresergebnis um rund 2.5% Portfolio mit Beteiligungen an zwei privaten Unternehmen selektiv ergänzt Verwaltungsrat beantragt Nennwertrückzahlung von unverändert CHF......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.05.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments achieves a balanced result in the 2023/2024 financial year
News Preview
Slight loss of CHF 1 million Net asset value per share (NAV) 0.3% higher after share buy-backs Mixed portfolio performance Unfavourable currency developments reduce annual result by around 2.5% Portfolio selectively supplemented with investments in two private companies Board of Directors proposes unchanged par value repayment of CHF 7.50 per......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.05.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 30.04.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 30.04.2024 01.05.2024 / 17:47 CET/CEST   in CHF Performance in %   30.04.2024   MTD FYTD CYTD NAV 254.66 2.6 2.6 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.04.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 15.04.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.04.2024 16.04.2024 / 17:47 CET/CEST   in CHF Performance in %   15.04.2024   MTD FYTD CYTD NAV 242.82 -2.1 -2.1 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.04.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 31.03.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.03.2024 02.04.2024 / 17:48 CET/CEST   in CHF Performance in %   31.03.2024   MTD FYTD CYTD NAV 248.10 0.4 0.3 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.04.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments publiziert inneren Wert je Aktie (NAV) von CHF 248.10 per 31. März 2024 und Quartalsgewinn von CHF 156 Millionen
News Preview
HBM Healthcare Investments erzielte im Schlussquartal des Geschäftsjahrs 2023/24 per Ende März einen Gewinn von CHF 156 Millionen. Damit konnte der Verlust aus den ersten neun Monate weitgehend wettgemacht werden. Der innere Wert je Aktie (NAV) stieg um 10.3 Prozent auf CHF 248.10 an.   Von der Quartalsperformance entfallen rund zwei Drittel auf ......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.04.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 248.10 as at 31 March 2024 and quarterly profit of CHF 156 million
News Preview
HBM Healthcare Investments generated a profit of CHF 156 million in the final quarter of the 2023/24 financial year as at the end of March. This largely made up for the loss from the first nine months. The net asset value per share (NAV) rose by 10.3 per cent to CHF 248.10.   Positive currency effects accounted for around two thirds of the quarte......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.03.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 15.03.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.03.2024 18.03.2024 / 17:47 CET/CEST   in CHF Performance in %   15.03.2024   MTD FYTD CYTD NAV 243.47 -1.4 -1.5 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.03.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 29.02.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 29.02.2024 01.03.2024 / 17:47 CET/CEST   in CHF Performance in %   29.02.2024   MTD FYTD CYTD NAV 247.01 7.6 -0.1 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.02.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 15.02.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.02.2024 16.02.2024 / 17:47 CET/CEST   in CHF Performance in %   15.02.2024   MTD FYTD CYTD NAV 243.93 6.3 -1.3 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.02.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 31.01.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.01.2024 01.02.2024 / 17:47 CET/CEST   in CHF Performance in %   31.01.2024   MTD FYTD CYTD NAV 229.55 2.0     ......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.01.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments publiziert Quartalsbericht per 31. Dezember 2023 und Kennzahlen für die ersten neun Monate des Geschäftsjahrs 2023/2024
News Preview
Berichtsquartal schliesst mit Verlust von CHF 87 Millionen. Für die 9-Monatsperiode summiert sich der Verlust auf CHF 158 Millionen Ungünstige Währungsentwicklungen ausschlaggebend Wertentwicklung im Rahmen der Vergleichsindizes  Ungünstige Währungsentwicklungen ziehen HBM Healthcare in die Verlustzone HBM Healthcare Investments schliesst da......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.01.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments publishes Quarterly Report as at 31 December 2023 with key figures for the first nine months of the 2023/2024 financial year
News Preview
Quarter under review closes with a loss of CHF 87 million. For the nine-month period, the loss totalled CHF 158 million Unfavourable currency developments were the decisive factor Performance is in line with relevant market indices  Unfavourable currency developments drag HBM Healthcare into the red HBM Healthcare Investments closed the third ......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.01.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 15.01.2024
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.01.2024 16.01.2024 / 17:47 CET/CEST   in CHF Performance in %   15.01.2024   MTD FYTD CYTD NAV 229.31 1.9     ......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.01.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 225.03 as at 31 December 2023
News Preview
HBM Healthcare Investments closed the 2023 calendar year with a negative performance due to unfavourable currency developments. The net asset value per share (NAV) fell by 8.3 percent to CHF 225.03. The share price declined by 5.4 percent to CHF 182.60. Currency developments had a negative impact of around 9.5 per cent on performance in 2023 (USD -......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.01.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments publiziert inneren Wert je Aktie (NAV) von CHF 225.03 per 31. Dezember 2023
News Preview
HBM Healthcare Investments schliesst das Kalendarjahr 2023 aufgrund von ungünstigen Währungsentwicklungen mit einer negativen Performance ab. Der innere Wert je Aktie (NAV) reduzierte sich um 8.3 Prozent auf CHF 225.03. Der Aktienkurs ging um 5.4 Prozent auf CHF 182.60 zurück. Die Währungsentwicklungen belasteten die Performance in 2023 mit rund 9.......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.01.2024
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
Key Figures 31.12.2023
News Preview
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.12.2023 03.01.2024 / 18:13 CET/CEST   in CHF Performance in %   31.12.2023   MTD FYTD CYTD NAV 225.03 -0.7 -8.7 ......
Themefolio
Profiler
Peergroup

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2025 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Tuesday, 16.12.2025, Calendar Week 51, 350th day of the year, 15 days remaining until EoY.